Aaron L Southren

Title: Innovations of Aaron L Southren in Ophthalmic Treatments

Introduction

Aaron L Southren, an accomplished inventor based in Valhalla, NY, has made significant contributions to the field of ophthalmic medicine. With a total of three patents to his name, Southren's work focuses on innovative pharmaceutical compositions aimed at treating ophthalmic inflammation and controlling intraocular pressure.

Latest Patents

Among his notable patents, Southren has developed a method utilizing tetrahydrocortisol to prevent elevations in intraocular pressure. This invention discloses pharmaceutical compositions that combine glucocorticoids and tetrahydrocortisol, allowing the anti-inflammatory benefits of glucocorticoids to be harnessed without risking elevated intraocular pressure, a common side effect of such treatments. Furthermore, he has also filed a patent for tetrahydrocortisol specifically in glaucoma therapy, detailing pharmaceutical compositions and methods to control intraocular pressure effectively.

Career Highlights

Throughout his career, Southren has worked with prestigious institutions, notably New York Medical College. His expertise in the field of ophthalmology and his innovative approach to treatment have positioned him as a key contributor in his area of specialization.

Collaborations

Collaboration has been a vital part of Southren's journey as an inventor. He has worked alongside esteemed colleagues, including Bernard I Weinstein and Gary G Gordon, which has likely fostered the development of his groundbreaking patents and research in ophthalmic inflammation.

Conclusion

In conclusion, Aaron L Southren’s innovative work in ophthalmic treatments, particularly the use of tetrahydrocortisol, exemplifies the impact of dedicated inventors in advancing medical science. His patents not only provide new treatment options but also pave the way for enhanced patient care in the field of ophthalmology.